Navigation Links
Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
Date:8/28/2008

OSLO, August 28 /PRNewswire-FirstCall/ --

- Results Further Support the Clinical Profile of This Novel Anti-Cancer Agent Under Development to Improve the Survival of Patients With Hormone Refractory Prostate Cancer (HRPC)

Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, today announced that the primary objective of its BC1-03 Phase II pain palliation study was met. The study showed that even single doses of Alpharadin in patients with painful bone metastases could produce increasing clinical benefit with increasing dose. Pain palliation is an important quality of life benefit in metastatic cancer patients. The trial also confirmed Alpharadin's benign side-effect profile and, importantly for a drug in this clinical setting, no significant bone marrow toxicity was observed.

In men with HRPC life expectancy can be as short as 18 months, and it is estimated that 100,000 men in the EU and USA die from the disease each year. In 85% of these men the tumor will have spread into the bones. These metastases are a significant problem as they can cause intractable and debilitating pain as well as contributing to a further reduction in life expectancy.

The BC1-03 study was a double-blind randomised pain control study comparing the palliative effects of four different single dose levels of Alpharadin in patients with bony metastatic HRPC. The drug was given by i.v. injection mainly on an outpatient basis. The palliative efficacy of Alpharadin was measured using an assessment of bone pain as well as the patient's consumption of analgesia. The primary study objective was to investigate whether there was a dose-response relationship with respect to pain palliation in this patient group. The study has shown the beneficial palliative effect of a single dose of Alpharadin and that there is a clear dose-response effect, with higher doses providing better pain relief.

The study also showed a dose-dependent reduction in bone al
'/>"/>

SOURCE Algeta
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
2. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
3. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
4. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
5. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
6. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
7. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
8. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
9. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
10. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
11. Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Sept. 2, 2014 /PRNewswire-iReach/ -- Ortho Development® Corporation (ODEV) ... Stem, the latest addition to its growing hip ... intended for use in total hip arthroplasty and ... Alpine was developed based ... ODEV,s engineers worked closely with a select team ...
(Date:9/2/2014)... ,S-HERTOGENBOSCH, the Netherlands , Sept. 2, ... expanded its North American operations through its subsidiary HealthLink ... fulfillment and order to cash services for medical device ... our global ERP platform. Building on the ... in Europe with customer service, ...
(Date:9/2/2014)... -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, ... Drew Young has joined the company as Senior ... will be responsible for leading the strategic direction of ... Bringing more than 20 years of experience ... pharmaceutical and biotech companies, Mr. Young comes to EMD ...
Breaking Medicine Technology:Ortho Development Receives FDA Clearance for Alpine Hip Stem 2HealthLink Europe opens North American medical warehouse operation 2EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 2EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 3EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 4
... CAMBRIDGE, Mass., Oct. 27 Novartis announced today that ... million over the next five years to expand its ... Mass.   "Novartis was the first global ... just a few years ago.  It has achieved prominence ...
... According to Millennium Research Group (MRG), the global ... arthroscope market generated over $30 million in 2010. ... to decreasing scope prices and greater market penetration ... unfavorable economic conditions, manufacturers are being forced to ...
Cached Medicine Technology:Novartis to Expand Global Research Headquarters in Cambridge, MA 2Novartis to Expand Global Research Headquarters in Cambridge, MA 3Novartis to Expand Global Research Headquarters in Cambridge, MA 4Despite Rising Procedure Volumes, the $30 Million European Arthroscope Market Experienced Nominal Growth in 2010 2Despite Rising Procedure Volumes, the $30 Million European Arthroscope Market Experienced Nominal Growth in 2010 3
(Date:9/2/2014)... TCG, a leading government technology strategy and IT consultancy, has ... companies in America for the seventh year in a row, ... 2013, 2012, 2011, 2010, 2009, 2008, and the Inc. 500 ... to 2013, ranking the company at position 3,708 on the ... 635 spots from 2013! More information is on TCG's ...
(Date:9/2/2014)... The Wm. Jennings Bryan Dorn Veterans Affairs Medical Center will ... Veterans and their families on September 24. , “Staff ... with valuable healthcare and benefit information,” said Medical Center Director ... where we can gather important input directly from Veterans to ... held 4:45 p.m. to 5:45 p.m. in the main lobby ...
(Date:9/2/2014)... Among women diagnosed with early-stage breast cancer in California, ... 1998 and 2011, although this procedure was not associated ... plus radiation, according to a study in the September ... find that surgery for the removal of one breast ... the other options examined in the study. , Randomized ...
(Date:9/2/2014)... Medex Analytic Services is delighted to ... Coral Springs, Fla. due to their greater than forecasted ... for the 2014 year by distinguishing Medex in the ... a higher level of service and professionalism in the ... the industry has responded.” , The location of the ...
(Date:9/2/2014)... Two new studies further confirm the health benefits of ... have a lower risk of ear, throat and sinus ... a similar trend when it comes to allergies. ... the immediate newborn period," said Dr. Jennifer Wu, an ... She was not involved in the new studies. ...
Breaking Medicine News(10 mins):Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:Medex Analytic Services Announces New Location for Corporate Headquarters 2Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2
... The American Society of Anesthesiologists, Action vs. RhetoricCORONA DEL ... doesn,t seem like very fair odds. Yet, that,s exactly ... Dr. Barry Friedberg, set the stage for last week ... (ASA) March 9 press release in which they claimed ...
... ... Beach, CA. (PRWEB) March 19, 2009 -- Secova, a leading provider ... a summary of the healthcare provisions in the $787 billion stimulus ... Obama’s new administration, Secova is working diligently to identify all possible ...
... services to group practices, multi-specialty clinics and community health centers, ... Associates. , ... Scottsdale, AZ (PRWEB) ... of medical transcription services to group practices, ...
... ALCMI,s founding organization, the Bonnie J. Addario Lung Cancer ... advertising campaign to raise $20 from one million people in ... CBS Outdoor and friends of the Foundation to raise awareness ... billboards in New York City, Los Angeles, Washington, D.C., San ...
... - Findings from the first in-depth study of patient ... with other acute care facilities without knowing it. ... meeting of the Society for Healthcare Epidemiology of America ... patients is directly transferred from one hospital to another, ...
... time to progress and cause irreversible damage, doctors say , , ... the sudden and tragic death Wednesday of actress Natasha Richardson, ... minor fall on a Canadian ski slope on Tuesday have ... been born into one of the most lauded acting families ...
Cached Medicine News:Health News:Dr. Barry Friedberg comments on David vs. Goliath: Who's Really in the Pursuit of Patient Safety & Satisfaction? 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 3Health News:MxSecure, Inc. Completes Custom Document Management Interface for Roanoke Neurological Associates 2Health News:MxSecure, Inc. Completes Custom Document Management Interface for Roanoke Neurological Associates 3Health News:Joan Gaeta Lung Cancer Foundation Donates $15,000 to Addario Lung Cancer Medical Institute (ALCMI) for Lung Cancer Research 2Health News:Joan Gaeta Lung Cancer Foundation Donates $15,000 to Addario Lung Cancer Medical Institute (ALCMI) for Lung Cancer Research 3Health News:Study finds extensive patient sharing among hospitals; could impact spread of infectious diseases 2Health News:Brain Hemorrhage Might Explain Natasha Richardson's Death 2Health News:Brain Hemorrhage Might Explain Natasha Richardson's Death 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: